DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR OMNIPAQUE 12
Clinical Trials for Omnipaque 12
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT00478556 | Omnipaque Versus Gastroview as Oral Contrast for Abdominal and Pelvic CT | Completed | GE Healthcare | Phase 4 | Patients who are scheduled by their health care provider for routine computed tomography (CT) scan will be asked to participate in this study. The primary purpose is to determine if there is a difference in patient preference for Omnipaque versus Gastroview as oral contrast for abdominal pelvic CT. A secondary objective is to evaluate if there is significant difference in bowel opacification for the two agents. |
NCT00478556 | Omnipaque Versus Gastroview as Oral Contrast for Abdominal and Pelvic CT | Completed | University of Alabama at Birmingham | Phase 4 | Patients who are scheduled by their health care provider for routine computed tomography (CT) scan will be asked to participate in this study. The primary purpose is to determine if there is a difference in patient preference for Omnipaque versus Gastroview as oral contrast for abdominal pelvic CT. A secondary objective is to evaluate if there is significant difference in bowel opacification for the two agents. |
NCT00587132 | Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma | Terminated | ChiRhoClin, Inc. | Phase 1/Phase 2 | The purpose of this study is to test if secretin-enhanced CT is a useful noninvasive screening tool for pancreatic cancer in a high-risk population. |
Trial ID | Title | Status | Sponsor | Phase | Summary |
Clinical Trial Conditions for Omnipaque 12
Condition Name
Condition MeSH
Clinical Trial Locations for Omnipaque 12
Trials by Country
Clinical Trial Progress for Omnipaque 12
Clinical Trial Phase
Clinical Trial Sponsors for Omnipaque 12
Sponsor Name